RE: Confidence to Bag and Aspirations1 Feb 2022 11:04
It all depends on what the results say. Does it prevent deaths? what's the hazard ratio etc.
Getting another 500% on just the P3 results requires a repeat of the P2 trial results. It's hard to imagine the possibilities with a readout that good. However if the results show only marginal efficacy (which could still be enough for commercialisation - the bar is not that high) then it's an entirely different situation. Most likely we will see something in-between.
Likely a spike on good news followed by announcements on next steps. Government support (any government but likely USA first), BARDA funding, orders? etc.
For me the best outcome is a buy out - straight share purchase from shareholders. Why? because it removes all responsibility from me in terms of deciding what to do with the shares if the company is successful. Others want to see SNG go it alone and see even higher SP levels on global sales and partnerships.
All the above are nice problems to have....